Celmatix Lands $1,499,997 New Financing

  • Feed Type
  • Date
    3/2/2012
  • Company Name
    Celmatix
  • Mailing Address
    12 Desbrosses Street New York, NY 10013
  • Company Description
    Celmatix, Inc. is a New York City-based biotechnology company targeting the reproductive medicine sector with products designed to improve reproductive technologies and outcomes. Our lead product under development is FertilArrayTM, an in vitro genetic diagnostic for assessing female egg quality and genetic indicators of female infertility.
  • Website
    http://www.celmatix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,499,997
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.